29 / January / 2025 AI could increase accuracy in clinical trials Study reveals that GPT-4 models outperform experts at selecting patients with heart failure, optimizing inclusion in clinical trials, and reducing operational costs Por Moura Leite Netto
14 / January / 2025 To reduce costs and increase diversity in clinical studies A US regulatory agency advocates analyzing treatment efficacy by combining observational studies with targeted data collection Por Editorial staff
19 / December / 2024 Fighting Alzheimer’s with science and empathy Brazilian biologist is leading research that seeks to develop a simple, less invasive method for diagnosing the disease that affects her mother Por Letícia Naísa
18 / December / 2024 Collaborative effort to unlock Down syndrome Focusing on personalized medicine, Argentine biologist Joaquin Espinosa outlines how recent advancements in research can help predict risks and enhance the quality of life for individuals with Down syndrome Por Moura Leite Netto
08 / November / 2024 When should medications be deprescribed? Physicians should suspend prescription of cardiovascular medications when there could be potential harm or if there are better alternatives, warn researchers Por Editorial staff
17 / September / 2024 New uses for existing drugs International programs weigh up costs and benefits in the search for new forms of treatment with existing drugs Por Editorial staff
25 / June / 2024 Jorge Kalil: Making vaccines in Brazil is like David versus Goliath The country is not investing enough in the technology needed to develop and produce vaccines for the biggest threats to public health, says the former Butantan director Por Moura Leite Netto
